* Inmode Ltd INMD.OQ reported quarterly adjusted earnings
of 34
cents per share for the quarter ended in January, lower than
the same quarter last year, when the company reported EPS of 72
cents. The mean expectation of six analysts for the quarter was
for earnings of 38 cents per share. Wall Street expected
results to range from 22 cents to 50 cents per share.
* Revenue fell 36.5% to $86.45 million from a year ago;
analysts
expected $101.67 million.
* Inmode Ltd's reported EPS for the quarter was 28 cents.
* The company reported quarterly net income of $23.82
million.
* Inmode Ltd shares had fallen by 0.7% this quarter and
lost 18.5%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 26.4%
in the last three months.
* In the last 30 days, four analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Inmode Ltd is
$20.00
This summary was machine generated from LSEG data August 1 at
01:53 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.38 0.34 Missed
Mar. 31 2024 0.41 0.32 Missed
Dec. 31 2023 0.67 0.71 Beat
Sep. 30 2023 0.64 0.61 Missed